TECHNOLOGY OVERVIEW AND APPLICATIONS IN THE PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY

Publisher: Upperton Limited

Access this content

Your content has been opened.

Please verify you are a human before downloading this content.

TECHNOLOGY OVERVIEW AND APPLICATIONS IN THE PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY has been emailed to . Entered the wrong email?

Don't see the content in your inbox?
Make sure to check your spam and other messages folders.

Can't get to your email right now?

To complete your registration and access this content, enter the sign-in code sent to your email.

Please enter a valid verification code.

Code sent to:

Also, remember to check in your spam, promotions, and other folders.

Register to access this content

By accessing content on the Pharmaceutical Manufacturing Resource Directory you agree to our Terms of Service and Privacy Policy; and, you acknowledge that your information may be shared with the content publisher.

TECHNOLOGY OVERVIEW AND APPLICATIONS IN THE PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY

In this article Dr Richard Johnson, Founding Director of Upperton Ltd, describes some of the basic principles of spray drying and how spray drying is typically being used in the pharmaceutical and biotechnology industry. Particular attention is focussed on four key applications, namely the stabilisation of biotherapeutics, enhancing the solubility of poorly soluble compounds, producing powders for inhaled delivery and microencapsulation for modified release

Similar content you might be interested in

GammaGuard CE® Sterile Workwear | Sales Sheet

Publisher: International Enviroguard

GammaGuard CE® Sterile Workwear | Sales Sheet

GammaGuard CE® Sales Sheet and Test Data

Download Content »

Optimizing Pharmaceutical Isolator Design

Publisher: Germfree Laboratories Inc

Optimizing Pharmaceutical Isolator Design

The isolator industry is pivotal to providing crucial solutions for safeguarding equipment and processes across a variety of sectors. Isolators ensure optimal performance and integrity, from laboratory experiments to industrial processes.

Download Content »

Cocrystals: A Regulatory Rebirth

Publisher: Triclinic Labs, Inc

Cocrystals: A Regulatory Rebirth

What is the impact of recent changes in FDA guidance on regulatory and intellectual property issues? The FDA reclassification of cocrystals as active pharmaceutical ingredients (APIs) has created exciting opportunities for the pharmaceutical industry. That reclassification means cocrystals can now be developed as if they were polymorphs, providing new avenues for dealing with poor API physical properties and extending intellectual property lifetimes. It is important to understand how the revised guideline impacts API development, regulatory submissions, and intellectual property protection. Those topics are discussed in this whitepaper. Also considered is the importance of identifying whether an API is a salt or a cocrystal, a critical classification from a regulatory point of view. In addition, a list of FDA-approved, marketed cocrystals is presented. Finally, recommendations for cocrystal screening, evaluation, formulation, and production at scale are given.

Download Content »